Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Colorcon
Moodys
McKinsey
Medtronic

Last Updated: January 25, 2022

DrugPatentWatch Database Preview

Litigation Details for Ferring Pharmaceuticals Inc. v. Serenity Pharmaceuticals, LLC (S.D.N.Y. 2017)


Email this page to a colleague

« Back to Dashboard

Ferring Pharmaceuticals Inc. v. Serenity Pharmaceuticals, LLC (S.D.N.Y. 2017)

Docket ⤷  Try it Free Date Filed 2017-12-20
Court District Court, S.D. New York Date Terminated
Cause 28:2201dj Declaratory Judgment Assigned To Colleen McMahon
Jury Demand None Referred To Stewart D. Aaron
Parties AVADEL SPECIALY PHARMACEUTICALS, LLC; FERRING INTERNATIONAL CENTER S.A.
Patents 6,613,960; 7,405,203; 7,560,429; 7,579,321; 7,799,761; 7,947,654; 8,802,624; 9,220,747; 9,504,647; 9,539,302
Attorneys James David Weinberger; Kristen Healey Cramer
Firms Fross Zelnick Lehrman & Zissu, P.C.; Jones Day (DC)
Link to Docket External link to docket
Small Molecule Drugs cited in Ferring Pharmaceuticals Inc. v. Serenity Pharmaceuticals, LLC
The small molecule drugs covered by the patents cited in this case are ⤷  Try it Free and ⤷  Try it Free .
Biologic Drugs cited in Ferring Pharmaceuticals Inc. v. Serenity Pharmaceuticals, LLC
The biologic drug covered by the patents cited in this case is ⤷  Try it Free .

Details for Ferring Pharmaceuticals Inc. v. Serenity Pharmaceuticals, LLC (S.D.N.Y. 2017)

Date Filed Document No. Description Snippet Link To Document
2017-04-28 1 Complaint United States Patent No. 7,405,203, United States Patent No. 7,579,321, and United States Patent No. 7,799,761…Certificate, No. US 7,405,203 C1 (collectively, “the ’203 patent”). The ’203 patent bears the title, “…Application”), which matured into United States Patent No. 7,405,203, and U.S. Application No. 10/706,100 (“… issued United States Patent No. 7,579,321 (“the ’321 patent”). The ’321 patent bears the title, “Pharmaceutical… issued United States Patent No. 7,799,761 (“the ’761 patent”). The ’761 patent bears the title, “Pharmaceutical External link to document
2018-06-28 101 Answer to Amended Complaint , United States Patent No. 7,405,203 (the “’203 patent”); 7,579,321 (the “’321 patent”); and 7,799,761…United States Patent Nos. 7,405,203 (the “’203 patent”), and 7,579,321 (the “’321 patent”) (collectively… (INFRINGEMENT OF U.S. PATENT NO. 7,405,203) 55. Counterclaimants incorporate…the ’203 patent on April 12, 2011 by issuing Ex Parte Reexamination Certificate No. US 7,405,203 C1. … (WILLFUL INFRINGEMENT OF U.S. PATENT NO. 7,405,203) 70. Counterclaimants incorporate External link to document
2018-07-19 115 Answer to Counterclaim United States Patent Nos. 7,405,203 (“the ’203 patent”) and 7,579,321 (“the ’321 patent”). 9. … (INFRINGEMENT OF U.S. PATENT NO. 7,405,203) 55. Ferring incorporates by… (WILLFUL INFRINGEMENT OF U.S. PATENT NO. 7,405,203) 70. Ferring incorporates by…Certificate No. US 7,405,203 C1 on April 12, 2011. Ferring states that the claims of the ’203 patent are invalid…issued Ex Parte Reexamination Certificate No. US 7,405,203 C1 on April 12, 2011. Ferring denies the remaining External link to document
2018-09-19 201 Declaration version of the original filed claims for U.S. Patent No. 7,405,203, # 2 Exhibit 18 - certified version of the… the original filed claims for U.S. Patent No. 7,579,321, # 3 Exhibit 19 - certified version of the Preliminary…December 2017 21 August 2020 1:17-cv-09922 Patent None District Court, S.D. New York External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Harvard Business School
Moodys
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.